VAKZINE ZUM SCHUTZ VON TIEREN GEGEN LEISHMANIA

The present invention is generally related to the prevention of leishmaniasis in animals, particularly infection caused by Leishmania sp., based on the use of Leishmania infantum P36 protein or an immunogenic fragment of the latter, or involving an expression system for the mentioned protein or frag...

Full description

Saved in:
Bibliographic Details
Main Authors RAMIRO IBANEZ, M. J, CASTILLO HERNANDEZ, J. A, GONZALEZ ASEGUINOLAZA, G, LARRAGA RODRIGUEZ DE VERA, V. E, LUCIENTES CURDI, J
Format Patent
LanguageGerman
Published 15.09.2009
Subjects
BASIC ELECTRIC ELEMENTS
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DEVICES USING STIMULATED EMISSION
ELECTRICITY
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention is generally related to the prevention of leishmaniasis in animals, particularly infection caused by Leishmania sp., based on the use of Leishmania infantum P36 protein or an immunogenic fragment of the latter, or involving an expression system for the mentioned protein or fragment - optionally in combination with a compound stimulating the production of a Th1-type cellular immune response - and comprising various vaccination protocols in application to Leishmania sp. based on the mentioned vaccine.
Bibliography:Application Number: AT20020702414T